Skip to content
Review

Iron dyshomeostasis and its neurobiological mechanisms in psychiatric disorders.

Aug 2026 · Molecular Psychiatry · 0 citations · 133 references
Medicine

TL;DR

This synthesis synthesizes multimodal evidence from human neuroimaging, post-mortem tissue analysis, clinical cohorts, and preclinical animal studies to delineate the distinct regulatory logics governing peripheral and cerebral iron metabolism, and constructs a unified mechanistic framework illustrating how diverse etiological factors drive region- and cell-specific iron perturbations and subsequent circuit dysfunction.

View source

Similar papers

Review Open access Aug 2026

Mitochondrial control of blood-brain barrier homeostasis in neuroinflammatory psychiatric disorders

Neuroinflammatory mechanisms are increasingly recognized in biologically defined subgroups of psychiatric disorders, yet the cellular interfaces linking peripheral immune activation to brain dysfunction remain incompletely understood. This review examines the blood-brain barrier (BBB) and neurovascular unit (NVU) as dy...

Larli Misael Pérez-López, Alberto Camacho-Morales, I. Howland-Álvarez et al. · 0 citations
Review Open access Sep 2026

Ferroptosis in major depressive disorder: Molecular mechanisms, cellular vulnerability, and therapeutic opportunities

Major depressive disorder (MDD) is a heterogeneous psychiatric disorder involving oxidative stress, neuroinflammation, mitochondrial dysfunction, impaired neuroplasticity, and metabolic dysregulation. Ferroptosis, an iron-dependent form of regulated cell death driven by phospholipid peroxidation and antioxidant defense...

De-Yue Kong, Rui-Qi Duan, Xiang-Yu Wang et al. · 0 citations
Review Open access Sep 2026

Energetic dysregulations in psychotic disorders: Targets for new therapeutics.

Converging findings point to brain- and body-wide energetic dysregulation in psychotic disorders, implicating metabolic abnormalities across different levels of investigation, including genetic, cellular, postmortem, and in vivo neuroimaging studies. The present review synthesizes this literature documenting aberrant e...

Jacey Anderson, Kai-Christian Sonntag, Thao Do Vy Le et al. · 0 citations
Review 2026

Microglial advances in psychiatric disorders.

Emerging therapeutic strategies targeting microglia were discussed, including anti-inflammatory approaches, functional reprogramming, neuromodulation techniques, and microglial replacement or niche engineering, indicating a paradigm shift from indiscriminate microglia inhibition to the precise modulation of specific fu...

J. R. de Jesus, I. S. Ribeiro, Marcos V. S. Pereira et al. · 0 citations
Open access Aug 2026

Emerging Advances in Neuropharmacology: Novel Therapeutic Targets for Neurodegenerative Disorders

Neurodegenerative diseases are a heterogeneous group of chronic and progressive disorders, which are characterized by selective neuronal destruction, synaptic malfunction and progressive cognitive and locomotor dysfunction. The major ones are Alzheimer disease, Parkinson disease, Huntington disease, and amyotrophic lat...

Nisha, Sumairah Qadir · 0 citations
Review Open access Sep 2026

Neurobiological mechanisms and brain network dysfunction in major depressive disorder: an integrative review

Major depressive disorder (MDD) is a prevalent and disabling psychiatric disorder characterized by persistent mood disturbances, cognitive impairments, and significant systemic consequences. Despite its substantial clinical burden, diagnosis remains challenging because current approaches rely largely on subjective symp...

D. Iskakova, Burcu Yener, A. Kamzanova et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.